Prospective Evaluation of Maternal Sleep Position Through 30 Weeks of Gestation and Adverse Pregnancy Outcomes.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 11 9 2019
medline: 31 3 2020
entrez: 11 9 2019
Statut: ppublish

Résumé

To examine the relationship between prospectively assessed maternal sleep position and subsequent adverse pregnancy outcomes. This was a secondary analysis of a prospective observational multicenter cohort study of nulliparous women with singleton gestations who were enrolled between October 2010 and May 2014. Participants had three study visits that were not part of clinical care. They prospectively completed in-depth sleep questionnaires between 6 0/7 and 13 6/7 weeks of gestation and 22 0/7 and 29 6/7 weeks of gestation, the first and third study visits. A subset of women also underwent level 3 home sleep tests using the Embletta Gold device. The primary outcome was a composite of adverse pregnancy outcomes such as stillbirth, a small-for-gestational-age newborn, and gestational hypertensive disorders. A total of 8,706 (of 10,038) women had data from at least one sleep questionnaire and for pregnancy outcomes, and they comprised the population for this analysis. The primary outcome occurred in 1,903 pregnancies (22%). There was no association between reported non-left lateral or supine sleep during the last week of the first visit (adjusted odds ratio [aOR] 1.00 [95% CI 0.89-1.14]) or third visit (aOR 0.99 [95% CI 0.89-1.11] and the composite or any individual outcome, except for an apparent protective effect for stillbirth at the third visit (aOR 0.27 (95% CI 0.09-0.75). Women with objectively measured supine sleep position for at least 50% of the time were no more likely than those in the supine position 50% or less of the time to have the composite adverse outcome. Going to sleep in the supine or right lateral position, as self-reported before the development of pregnancy outcome and objectively assessed through 30 weeks of gestation, was not associated with an increased risk of stillbirth, a small-for-gestational-age newborn, or gestational hypertensive disorders.

Identifiants

pubmed: 31503146
doi: 10.1097/AOG.0000000000003458
pmc: PMC6768734
mid: NIHMS1534696
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-676

Subventions

Organisme : NICHD NIH HHS
ID : U10 HD063053
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

BMJ. 2011 Jun 14;342:d3403
pubmed: 21673002
Int J Gynaecol Obstet. 2013 Jun;121(3):261-5
pubmed: 23507553
Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007623
pubmed: 23543552
PLoS One. 2014 Dec 23;9(12):e115760
pubmed: 25535960
Obstet Gynecol. 2015 Feb;125(2):347-55
pubmed: 25568999
Am J Obstet Gynecol. 2015 Apr;212(4):539.e1-539.e24
pubmed: 25648779
Am J Obstet Gynecol. 2015 Apr;212(4):542.e1-127
pubmed: 25746730
BMC Pregnancy Childbirth. 2016 May 18;16(1):115
pubmed: 27194093
J Physiol. 2017 Feb 15;595(4):1213-1221
pubmed: 27871127
Obstet Gynecol. 2017 Jan;129(1):31-41
pubmed: 27926645
Sleep Med Rev. 2017 Dec;36:107-115
pubmed: 28012784
JAMA. 2017 Mar 14;317(10):1047-1056
pubmed: 28291893
PLoS One. 2017 Jun 13;12(6):e0179396
pubmed: 28609468
BJOG. 2018 Jan;125(2):254-262
pubmed: 29152887
J Clin Sleep Med. 2018 Jul 15;14(7):1205-1208
pubmed: 29991424
Am J Obstet Gynecol. 1984 Mar 15;148(6):764-71
pubmed: 6702946
Obstet Gynecol. 1980 Feb;55(2):203-5
pubmed: 7352082
Int J Gynaecol Obstet. 1996 Dec;55(3):213-8
pubmed: 9003945
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183

Auteurs

Robert M Silver (RM)

University of Utah, Salt Lake City, Utah; RTI International, Research Triangle Park, North Carolina; Yale University, New Haven, Connecticut; University of Pittsburgh, Pittsburgh, Pennsylvania; Oregon Health & Science University, Portland, Oregon; Northwestern University, Evanston, Illinois; Case Western Reserve University, Cleveland, Ohio; Indiana University, Bloomington, Indiana; University of Pennsylvania, Philadelphia, Pennsylvania; Columbia University, New York, New York; University of South Florida, Tampa, Florida; University of California-Irvine, Irvine, California; Johns Hopkins Medicine, Baltimore, Maryland; University of Texas Medical Branch at Galveston, Galveston, Texas; and Brigham and Women's Hospital, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH